g6 cgm (Dexcom Inc)
90
Structured Review
Dexcom Inc
g6 cgm
G6 Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/g6+cgm/dexcom+g6/nct04536480-6-15-15
Average 90 stars, based on 1 article reviews
G6 Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/g6+cgm/dexcom+g6/nct04536480-6-15-15
Average 90 stars, based on 1 article reviews
g6 cgm - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Biomarker Discovery:Article Title: Continuous glucose monitoring in gestational diabetes mellitus: a tool, not a treatment. Article Snippet: I mproving maternal and child outcomes in pregnant patients with gestational diabetes mellitus (GDM) primarily hinges on achieving tight maternal glycemic control during pregnancy.. Accurate glucose monitoring is the first step in achieving control.. Real-time continuous glucose monitoring (CGM) provides more detailed information than traditional self-monitoring of blood glucose (SMBG), and its use in pregnant patients with type 1 diabetes mellitus has been shown to improve neonatal outcomes. Control:Article Title: Continuous glucose monitoring in gestational diabetes mellitus: a tool, not a treatment. Article Snippet: I mproving maternal and child outcomes in pregnant patients with gestational diabetes mellitus (GDM) primarily hinges on achieving tight maternal glycemic control during pregnancy.. Accurate glucose monitoring is the first step in achieving control.. Real-time continuous glucose monitoring (CGM) provides more detailed information than traditional self-monitoring of blood glucose (SMBG), and its use in pregnant patients with type 1 diabetes mellitus has been shown to improve neonatal outcomes. other:Article Title: Multicentric Before/After Study to Assess the Efficacy and Safety of DBL-4pen Mobile Application on Glycemic Control in Patients With Type 2 Diabetes Article Snippet: CGM parameters (such as alarms and alerts) will be matched with their usual treatment and patients will be asked to make equivalent therapeutic decisions based on the values of Article Title: Multicentric Before/After Study to Assess the Efficacy and Safety of DBL-4pen Mobile Application on Glycemic Control in Patients With Type 2 Diabetes Article Snippet: All patients are equipped with a Article Title: Continuous Glucose Monitoring Among Patients With Type 1 Diabetes in Rwanda (CAPT1D) Phase I: Prospective Observational Feasibility Study Article Snippet: Phase I of the study was conducted over 12 months, using the Article Title: Impact of Meal Timing on Glycemic Profiles in Adolescents With Type 2 Diabetes Article Snippet: All participants and their families will receive training on the use and application of the Article Title: A Pilot Trial of Continuous Glucose Monitoring (CGM) Technology in Preoperative Assessment Clinic Article Snippet: Measure Description: Accuracy of CGM technology utilizing Article Title: Managing Diabetes in Older Adults: Current Approaches in Long-Term Care Facilities. Article Snippet: As of 2020, there are over 15,000 nursing homes in the U.S., accommodating 1.6 million residents [4].. Most of these residents are older adults, with those aged 65 and above making 80% of the population [5].. By 2060, the number of people aged 65 and over is projected to reach 94.7 million, accounting for 23.4% of the U.S. population, compared to 56.1 million (16.9%) in 2020. |